The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 3, 2013, Pages 382-389

  Strasser, Andrew A ^a,b   Ashare, Rebecca L ^a   Kaufman, Madeline ^a   Tang, Kathy Z ^a   Mesaros, A Clementina ^a   Blair, Ian A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE; MENTHOL; NICOTINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MALE; ODOR; OPEN STUDY; PRIORITY JOURNAL; SMOKE; SMOKING; TASTE; TOBACCO DEPENDENCE; TOPOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DEOXYGUANOSINE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; MALE; MENTHOL; MIDDLE AGED; PROGNOSIS; SMELL; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TASTE; YOUNG ADULT;

EID: 84876558586     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1097     Document Type: Article

References (45)

1. H.R. 1256-111th Congress: Family Smoking Prevention and Tobacco Control Act. 2009. [cited 2012 Jul 30] Available from: http://www. govtrack.us/congress/ bills/111/hr1256.
2. Lawrence D, Rose A, Fagan P, Moolchan ET, Gibson JT, Backinger CL. National patterns and correlates of mentholated cigarette use in the United States. Addiction 2010;105:13-31.
3. Tobacco Products Scientific Advisory Committee. (TPSAC). Menthol Cigarettes and Public Health: Review of the Scientific Evidence and Recommendations. 2011. [cited 2012 Jul 30] Available from: http://www.fda.gov/ downloads/AdvisoryCommittees/Committees- MeetingMaterials/ TobaccoProductsScientificAdvisoryCommittee/UCM269697.pdf.
4. Sidney S, Tekawa IS, Friedman GD, Sadler MC, Tashkin DP. Mentholated cigarette use and lung cancer. Arch InternMed1995;155:727-32.
5. Murray RP, Connett JE, Skeans MA, Tashkin DP. Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res 2007; 9:101-7. (Pubitemid 47009049)
6. Carpenter CL, Jarvik ME, Morgenstern H, McCarthy WJ, London SJ. Mentholated cigarette smoking and lung-cancer risk. Ann Epidemiol 1999;9:114-20. (Pubitemid 29072769)
7. US Department of Health and Human Services. (USDHHS). Tobacco Use Among U.S. Racial/Ethnic Minority Groups-African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders,and Hispanics:AReport of the Surgeon General. Atlanta,GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1998.
8. Perez-Stable EJ, Fuentes-Afflick E. Role of clinicians in cigarette smoking prevention. West J Med 1998;169:23-9. (Pubitemid 28340453)
9. McCarthy WJ, Caskey NH, Jarvik ME, Gross TM, Rosenblatt MR, Carpenter C. Menthol vs nonmenthol cigarettes: effects on smoking behavior. Am J Public Health 1995;85:67-72.
10. Ahijevych K, Parsley LA. Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addict Behav 1999;24:115-20. (Pubitemid 29021872)
11. Pickworth WB, Moolchan ET, Berlin I, Murty R. Sensory and physiologic effects of menthol and non-menthol cigarettes with differing nicotine delivery. Pharmacol Biochem Behav 2002;71:55-61. (Pubitemid 34102463)
12. Caskey NH, Jarvik ME, McCarthy WJ, Rosenblatt MR, Gross TM, Carpenter CL. Rapid smoking of menthol and nonmenthol cigarettes by black and white smokers. Pharmacol Biochem Behav 1993;46:259-63.
13. Miller GE, Jarvik ME, Caskey NH, Segerstrom SC, Rosenblatt MR, McCarthy WJ. Cigarette mentholation increases smokers' exhaled carbon monoxide levels. Experimental Clin Psychopharmacol 1994;2: 154-60.
14. Jarvik ME, Tashkin DP, Caskey NH, McCarthy WJ, Rosenblatt MR. Mentholated cigarettes decrease puff volume of smoke and increase carbon monoxide absorption. Physiol Behav 1994;56:563-70. (Pubitemid 24269581)
15. Nil R, Battig K. Separate effects of cigarette smoke yield and smoke taste on smoking behavior. Psychopharmacology (Berl) 1989;99:54-9. (Pubitemid 19201714)
16. Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res 2007;9:873-81. (Pubitemid 47190155)
17. Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ. The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res 2005;7:581-90. (Pubitemid 41600916)
18. Clark PI, Gautam S, Gerson LW. Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest 1996;110:1194-8. (Pubitemid 26380472)
19. Ahijevych K, Gillespie J, Demirci M, Jagadeesh J. Menthol and nonmenthol cigarettes and smoke exposure in black and white women. Pharmacol Biochem Behav 1996;53:355-60. (Pubitemid 26059200)
20. Muscat JE, Stellman SD, Caraballo RS, Richie JP. Time to first cigarette after waking predicts cotinine levels. Cancer Epidemiol Biomarkers Prev 2009;18:3415-20.
21. Heck JD. Smokers of menthol and nonmenthol cigarettes exhibit similar levels of biomarkers of smoke exposure. Cancer Epidemiol Biomarkers Prev. 2009;18:622-9.
22. Borgerding M,Bodnar J,Wingate D.The1999MassachusettsBenchmark Study: Final Report. July 2000. [cited 2012 Aug 28] Available from: http://legacy-dcucsfedu/documentStore/e/p/m/epm46a00/Sepm46a00pdf.
23. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence. Addict Behav 1994;19:33-9. (Pubitemid 24072190)
24. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86:1119-27.
25. Gordon SM, Brinkman MC, Meng RQ, Anderson GM, Chuang JC, Kroeger RR, et al. Effect of cigarette menthol content on mainstream smoke emissions. Chem Res Toxicol 2011;24:1744-53.
26. Strasser AA, Ashare RL, Kozlowski LT, Pickworth WB. The effect of filter vent blocking and smoking topography on carbon monoxide levels in smokers. Pharmacol Biochem Behav 2005;82:320-9. (Pubitemid 41727943)
27. Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, et al. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiol Biomarkers Prev 2011; 20:234-8.
28. Strasser AA, Tang KZ, Sanborn PM, Zhou JY, Kozlowski LT. Behavioral filter vent blocking on the first cigarette of the day predicts which smokers of light cigarettes will increase smoke exposure from blocked vents. Experimental Clin Psychopharmacol 2009;17: 405-12.
29. Lee EM, Malson JL, Waters AJ, Moolchan ET, Pickworth WB. Smoking topography: reliability and validity in dependent smokers. Nicotine Tob Res 2003;5:673-9. (Pubitemid 37304842)
30. Benowitz NL, Jacob P III, Bernert JT, Wilson M, Wang L, Allen F, et al. Carcinogen exposure during short-term switching from regular to "light" cigarettes. Cancer Epidemiol Biomarkers Prev 2005;14: 1376-83. (Pubitemid 40807334)
31. Zacny JP, Stitzer ML, Brown FJ, Yingling JE, Griffiths RR. Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. J Pharmacol Experimental Ther 1987;240:554-64. (Pubitemid 17018440)
32. Hu CW, Wang CJ, Chang LW, Chao MR. Clinical-scale high-throughput analysis of urinary 8-oxo-7,8-dihydro-20-deoxyguanosine by isotope- dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Clin Chem 2006;52:1381-8. (Pubitemid 43956031)
33. Mesaros C, Arora JS, Wholer A, Vachani A, Blair IA. 8-Oxo-20- deoxyguanosine as a biomarker of tobacco-smoking-induced oxidative stress. Free Radic Biol Med 2012;53:610-7.
34. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9. (Pubitemid 37542453)
35. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-20- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387:147-63. (Pubitemid 28009270)
36. Cooke MS, Lunec J, Evans MD. Progress in the analysis of urinary oxidative DNA damage. Free Radic Biol Med 2002;33:1601-14. (Pubitemid 35462001)
37. Rangiah K, Hwang WT, Mesaros C, Vachani A, Blair IA. Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS. Bioanalysis 2011;3:745-61.
38. Benowitz NL, Samet JM. The threat of menthol cigarettes to U.S. public health. N Engl J Med 2011;364:2179-81.
39. StrasserAA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA.New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend 2007;86:294-300. (Pubitemid 44821611)
40. Carpenter CM, Wayne GF, Connolly GN. The role of sensory perception in the development and targeting of tobacco products. Addiction 2007;102:136-47. (Pubitemid 46006479)
41. Hersey JC, Ng SW, Nonnemaker JM, Mowery P, Thomas KY, Vilsaint MC, et al. Are menthol cigarettes a starter product for youth? Nicotine Tob Res 2006;8:403-13. (Pubitemid 43977042)
42. Villanti AC, Giovino GA, Barker DC, Mowery PD, Sevilimedu V, Abrams DB. Menthol brand switching among adolescents and young adults in the National Youth Smoking Cessation Survey. Am J Public Health 2012;102:1310-12.
43. O'Connor RJ, Bansal-Travers M, Carter LP, Cummings KM. What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand. Addiction 2012;107: 1330-8.
44. Levy DT, Pearson JL, Villanti AC, Blackman K, Vallone DM, Niaura RS, et al. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health 2011;101:1236-40.
45. Caraballo R. Menthol and demographics. Washington, D.C.: Food and Drug Administration Tobacco Products Scientific Advisory Committee; 2010.